Evaluation of Synergistic Effect of Nicotinic Acid with Imipenem as Antibiofilm for Clinical Pseudomonas Aeruginosa Isolates
The present study aims to evaluate the synergistic activity of nicotinic acid (NIC) with the Imipenem (IMI) as an anti-biofilm for clinical isolated Pseudomonas aeruginosa. The values of minimum inhibitor concentration (MICs) for IMI and NIC (Separately) against P. aeruginosa were (16) ug/mL and (8) ug/ml respectively. Whereas, the concentration of NIC with IMI (as combined) for biofilm inhibition was 1 ug/ml for NIC and 4 ug/ml for IMI. The combining of NIC with IMI showed synergistic efficacy against formation of bacterial biofilm (at MIC levels). These results provide a conclusion that NIC combined with IMI is can be considered as a successful prospective treatment against the biofilm produced by P. aeruginosa and as antibacterial medication.